Treatment of Infections by Cryptic Aspergillus Species

Mycopathologia

Volumn 178, Issue 5-6, 2014, Pages 441-445

  Nedel, Wagner L ^a,b   Pasqualotto, Alessandro C ^a,c  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

^c Irmandade Santa Casa de Misericórdia de Porto Alegre   (Brazil)

Author keywords

Cryptic species; Invasive aspergillosis; Treatment

Indexed keywords

ASPERGILLUS;

ANTIFUNGAL AGENT;

ASPERGILLOSIS; ASPERGILLUS; CLASSIFICATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; HUMANS; MICROBIAL SENSITIVITY TESTS; TREATMENT OUTCOME;

EID: 84912019912     PISSN: 0301486X     EISSN: 15730832     Source Type: Journal    
DOI: 10.1007/s11046-014-9811-z     Document Type: Article

References (31)

1. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis. 2005;5:609–22.
2. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF, et al. Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–60.
3. Alastruey-Izquierdo A, Mellado E, Peláez T, Pemán J, Zapico S, Alvarez M, Rodríguez-Tudela JL, Cuenca-Estrella M, et al. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob Agents Chemother. 2013;57:3380–7.
4. Balajee SA, Gribskov JL, Hanley E, Nickle D, Marr KA. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell. 2005;4:625.
5. Yaguchi T, Horie Y, Tanaka R, Matsuzawa T, Ito J, Nishimura K. Molecular phylogenetics of multiple genes on Aspergillus section Fumigati isolated from clinical specimens in Japan. Nihon Ishinkin Gakkai Zasshi. 2007;48:37–46.
6. Gurcan S, Tikvesli M, Ustundag S, Ener B. A case report on Aspergillus lentulus pneumonia. Balkan Med J. 2013;30:429–31.
7. Balajee SA, Gribskov J, Brandt M, Ito J, Fothergill A, Marr KA. Mistaken identity: neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatus. J Clin Microbiol. 2005;43:5996.
8. Hong SB, Go SJ, Shin HD, Frisvad JC, Samson RA. Polyphasic taxonomy of Aspergillus fumigatus and related species. Mycologia. 2005;97:1316–29.
9. Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, et al. Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: Where are we and where should we go from here? J Clin Microbiol. 2009;47:877–84.
10. Nilsson R, Ryberg M, Kristiansson E, Abarenkov K, Larsson KH, Koljalg U. Taxonomic reliability of DNA sequences in public sequence databases: A fungal perspective. PLoS ONE. 2006;1:e59.
11. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408–15.
12. Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, et al. Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis. 2007;44:1289–97.
13. Marr K, Schlamm H, Rottinghaus S, Jagannatha S, Bow E, Wingard J, Pappas P, Herbrecht R, Walsh T, Maertens J, Marr K, Schlamm H, Rottinghaus S, Jagannatha S, Bow E, Wingard J, et al. A randomised, double-blind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment, in 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), London, UK, 2012.
14. Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, et al. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis. Med Mycol. 2013;51:128–35.
15. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50:1091–100.
16. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50:1101–11.
17. Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, et al. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009;47:3138–41.
18. Alhambra A, Catalán M, Moragues MD, Brena S, Pontón J, Montejo JC, et al. Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease. Rev Iberoam Micol. 2008;25:246–9.
19. Montenegro G, Puch SS, Jewtuchowicz VM, Pinoni MV, Relloso S, Temporitti E, et al. Phenotypic and genotypic characterization of Aspergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis. J Med Microbiol. 2009;58:391–5.
20. Symoens F, Haase G, Pihet M, Carrere J, Beguin H, Degand N, et al. Unusual Aspergillus species in patients with cystic fibrosis. Med Mycol. 2010;48:S10–6.
21. Zbinden A, Imhof A, Wilhelm J, Ruschitzka F, Wild P, Bloemberg GV, et al. Fatal outcome after heart transplantation caused by Aspergillus lentulus. Transpl Infect Dis. 2012;14:E60–3.
22. Gyotoku H, Izumikawa K, Ikeda H, Takazono T, Morinaga Y, Nakamura S, et al. A case of bronchial aspergillosis caused by Aspergillus udagawae and its mycological features. Med Mycol. 2012;50:631–6.
23. Posteraro B, Mattei R, Trivella F, Maffei A, Torre A, de Carolis E, et al. Uncommon Neosartorya udagawae fungus as a causative agent of severe corneal infection. J Clin Microbiol. 2011;49:2357–60.
24. Vinh DC, Shea YR, Sugui JA, Parrilla-Castellar ER, Freeman AF, Campbell JW, et al. Clin Infect Dis. 2009;49:102–11.
25. Shigeyasu C, Yamada M, Nakamura N, Mizuno Y, Sato T, Yaguchi T. Keratomycosis caused by Aspergillus viridinutans: An Aspergillus fumigatus-resembling mold presenting distinct clinical and antifungal susceptibility patterns. Med Mycol. 2012;50:525–8.
26. Vinh DC, Shea YR, Jones PA, Freeman AF, Zelazny A, Holland SM. Chronic invasive aspergillosis caused by Aspergillus viridinutans. Emerg Infect Dis. 2009;15:1292–4.
27. Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification. Antimicrob Agents Chemother. 2008;52:1244–51.
28. Peláez T, Alvarez-Pérez S, Mellado E, Serrano D, Valerio M, Blanco JL, et al. Invasive aspergillosis caused by cryptic Aspergillus species: A report of two consecutive episodes in a patient with leukaemia. J Med Microbiol. 2013;62:474–8.
29. Balajee SA, Lindsey MD, Iqbal N, Ito J, Pappas PG, Brandt ME. Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods. J Clin Microbiol. 2007;45:2701–3.
30. Egli A, Fuller J, Humar A, Lien D, Weinkauf J, Nador R, et al. Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis. Transplantation. 2012;94:403–10.
31. Chiu YL, Liaw SJ, Wu VC, Hsueh PR. Peritonitis caused by Aspergillus sydowii in a patient undergoing continuous ambulatory peritoneal dialysis. J Infect. 2005;51:e159–61.